These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 12183028)
1. The prion protein in human neurodegenerative disorders. Kovacs GG; Zerbi P; Voigtländer T; Strohschneider M; Trabattoni G; Hainfellner JA; Budka H Neurosci Lett; 2002 Sep; 329(3):269-72. PubMed ID: 12183028 [TBL] [Abstract][Full Text] [Related]
2. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Masliah E Acta Neuropathol; 2000 Mar; 99(3):296-304. PubMed ID: 10663973 [TBL] [Abstract][Full Text] [Related]
3. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110 [TBL] [Abstract][Full Text] [Related]
4. Patterns of Tau and α-Synuclein Pathology in the Visual System. Rahimi J; Milenkovic I; Kovacs GG J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267 [TBL] [Abstract][Full Text] [Related]
6. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131 [TBL] [Abstract][Full Text] [Related]
7. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Takeda A; Mallory M; Sundsmo M; Honer W; Hansen L; Masliah E Am J Pathol; 1998 Feb; 152(2):367-72. PubMed ID: 9466562 [TBL] [Abstract][Full Text] [Related]
8. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Lee VM; Giasson BI; Trojanowski JQ Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877 [TBL] [Abstract][Full Text] [Related]
9. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Popescu A; Lippa CF; Lee VM; Trojanowski JQ Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612 [TBL] [Abstract][Full Text] [Related]
10. [Expression of proteins related neurodegeneration in autopsy brains of the aged]. Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589 [TBL] [Abstract][Full Text] [Related]
11. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831 [TBL] [Abstract][Full Text] [Related]
12. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases]. Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
14. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
15. Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles. Nemes Z; Devreese B; Steinert PM; Van Beeumen J; Fésüs L FASEB J; 2004 Jul; 18(10):1135-7. PubMed ID: 15132984 [TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Galvin JE; Giasson B; Hurtig HI; Lee VM; Trojanowski JQ Am J Pathol; 2000 Aug; 157(2):361-8. PubMed ID: 10934140 [TBL] [Abstract][Full Text] [Related]
18. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Goedert M Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313 [TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486 [TBL] [Abstract][Full Text] [Related]
20. Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course. Saito Y; Kawai M; Inoue K; Sasaki R; Arai H; Nanba E; Kuzuhara S; Ihara Y; Kanazawa I; Murayama S J Neurol Sci; 2000 Aug; 177(1):48-59. PubMed ID: 10967182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]